Sandoz files antitrust litigation against Amgen over etanercept biosimilar access....
Neurocrine Biosciences Competitors or Alternatives
Neurocrine Biosciences's top competitors include Cerecin, Alzheon and Alector.
Neurocrine Biosciences VS Cerecin
Cerecin is a top competitor of Neurocrine Biosciences. Cerecin was founded in 2001, and is headquartered in Singapore, Central Singapore. Like Neurocrine Biosciences, Cerecin also competes in the Biotechnology field. Cerecin generates $2.3B less revenue vs. Neurocrine Biosciences.
Neurocrine Biosciences VS Alzheon
Alzheon is seen as one of Neurocrine Biosciences's top competitors. Alzheon is headquartered in Framingham, Massachusetts, and was founded in 2013. Like Neurocrine Biosciences, Alzheon also operates in the Biotechnology field. Alzheon generates 0.36% the revenue of Neurocrine Biosciences.
Neurocrine Biosciences VS Alector
Alector has been one of Neurocrine Biosciences's top competitors. Alector's headquarters is in South San Francisco, California, and was founded in 2013. Like Neurocrine Biosciences, Alector also works within the Biotechnology industry. Alector generates 4.27% of Neurocrine Biosciences's revenue.
Looking for similar companies to Neurocrine Biosciences?
Similar Companies
Companies in San Diego with revenue in $1.0-5.0B range
See 30 companies
Companies in San Diego with employees in 1.0-5.0K rangeSee 65 companies
Biotechnology companies with revenue in $1.0-5.0B rangeSee 56 companies
Companies in San Diego County with revenue in $1.0-5.0B rangeSee 40 companies
Companies in San Diego County with employees in 1.0-5.0K rangeSee 95 companies
Biotechnology companies with employees in 1.0-5.0K rangeSee 114 companies
Pharmaceuticals companies with revenue in $1.0-5.0B rangeSee 144 companies
Pharmaceuticals & Biotechnology companies with revenue in $1.0-5.0B rangeSee 195 companies
Pharmaceuticals companies with employees in 1.0-5.0K rangeSee 203 companies
Trending News for Neurocrine Biosciences and Neurocrine Biosciences's Competitors
NEW BRUNSWICK (dpa-AFX) - Drug major Johnson & Johnson (JNJ), while reporting significantly higher first-quarter earnings with increased sales, on Tues...
Merck & Co Inc MRK and privately held Cyprumed GmbH signed a non-exclusive license and option agreement on Tuesday to develop oral formulations of Merc...
--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahea...
Mounjaro's launch in India sparks a surge in patient demand as Eli Lilly gains a market edge ahead of Novo Nordisk and upcoming generic competition. re...
Abbott Laboratories ABT on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.4...
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q...
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....
SNY shares preliminary data from phase II study on amlitelimab in moderate-to-severe asthma. It also provides updates on lunsekimig and itepekimab stud...
Bristol Myers Squibb announced the phase 3 ODYSSEY─HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New Y...
Frequently Asked Questions about Neurocrine Biosciences
Who are Neurocrine Biosciences's top competitors?
Neurocrine Biosciences's top 3 competitors are Cerecin, Alzheon, Alector.Who is similar to Neurocrine Biosciences?
Cerecin is the most similar to Neurocrine Biosciences. Alzheon and Alector are also similar to Neurocrine Biosciences.
Are Neurocrine Biosciences and Cerecin competitors?
Yes, Cerecin is one of Neurocrine Biosciences’s top competitors.